Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Despite their common use as an empirical combination therapy for the better part of a decade, there has been a recent association between combination therapy with vancomycin and piperacillin-tazobactam and high rates of acute kidney injury (AKI). The reasons for this increased association are unclea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Karino, Shigehiko, Kaye, Keith S., Navalkele, Bhagyashri, Nishan, Bakht, Salim, Madiha, Solanki, Shantanu, Pervaiz, Amina, Tashtoush, Nader, Shaikh, Hamadullah, Koppula, Sunitha, Martin, Emily T., Mynatt, Ryan P., Murray, Kyle P., Rybak, Michael J., Pogue, Jason M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879358/
https://ncbi.nlm.nih.gov/pubmed/27067325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03011-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados